Friday, July 10, 2026
🇺🇸 FDA

biotech · NSCLC Stage IV · Poliomyelitis

BioMarin Pharmaceutical

Biotech Pharmaceutical Co.,

BioMarin Pharmaceutical clinical programs — 40 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
770 Lindaro Street, San Rafael, CA 94901, US HQ
1997 Founded
3,171 Employees
NMPA registrant Type
Company details
Status
Public
HQ
770 Lindaro Street, San Rafael, CA 94901, US
Founded
1997
Employees
3,171
Programs
40
Drugs
37
Patents
0
Official website ↗ All projects Drug pipeline News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

BioMarin Pharmaceutical projects

40 ClinicalTrials.gov programs sponsored by BioMarin Pharmaceutical.

BioMarin Pharmaceutical has 40 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

40 programs

Clinical programs

  1. Faceptor

    Biotech Pharmaceutical Co.,

    Breast Cancer Metastatic

    phase 3 small molecule completed

    2 trials

  2. Nanocovax

    Biotech Pharmaceutical Co.,

    SARS-CoV-2 Infection

    phase 3 mab completed

    1 trial

  3. Olorofim

    Biotech Pharmaceutical Co.,

    Invasive Aspergillosis

    phase 3 small molecule active

    1 trial

  4. Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

    Biotech Pharmaceutical Co.,

    Influenza

    phase 3 mab active

    1 trial

  5. Recombinant Human VEGF Receptor-Fc Fusion Protein

    Biotech Pharmaceutical Co.,

    Neovascular Age-related Macular Degeneration

    phase 3 mab completed

    1 trial

  6. SARS-CoV-2 mRNA Vaccine

    Biotech Pharmaceutical Co.,

    COVID-19

    phase 3 mab active

    1 trial

  7. Stimus (NNG-DEPO)

    Biotech Pharmaceutical Co.,

    Anemia

    phase 3 mab completed

    1 trial

  8. Walvax PCV13-TT

    Biotech Pharmaceutical Co.,

    Pneumococcal Disease, Invasive

    phase 3 mab active

    1 trial

  9. eN-Lac®

    Biotech Pharmaceutical Co.,

    Perennial Allergic Rhinitis

    phase 3 mab completed

    1 trial

  10. pegcyte

    Biotech Pharmaceutical Co.,

    Breast Cancer Female

    phase 3 small molecule completed

    1 trial

  11. COVAXIN(BBV152)

    Biotech Pharmaceutical Co.,

    Corona Virus Infection

    phase 2 mab completed

    1 trial

  12. Chidamide

    Biotech Pharmaceutical Co.,

    Relapsed or Refractory Peripheral T-cell Lymphoma

    phase 2 small molecule active

    1 trial

  13. Chidamide

    Biotech Pharmaceutical Co.,

    Hepatocellular Carcinoma (HCC)

    phase 2 small molecule terminated

    1 trial

  14. EPI-321

    Biotech Pharmaceutical Co.,

    Facioscapulohumeral Muscular Dystrophy

    phase 2 mab active

    1 trial

  15. Laminectomy

    Biotech Pharmaceutical Co.,

    Acute Spinal Cord Injury

    phase 2 other active

    1 trial

  16. Olorofim

    Biotech Pharmaceutical Co.,

    Invasive Fungal Infections

    phase 2 small molecule completed

    1 trial

  17. PI-88

    Biotech Pharmaceutical Co.,

    Lung Cancer

    phase 2 small molecule completed

    1 trial

  18. Placebo

    Biotech Pharmaceutical Co.,

    Hemophilic Arthropathy

    phase 2 small molecule completed

    1 trial

  19. SCB01A

    Biotech Pharmaceutical Co.,

    Head and Neck Neoplasms

    phase 2 small molecule terminated

    1 trial

  20. SHJ002/Vehicle

    Biotech Pharmaceutical Co.,

    Dry Eye Disease

    phase 2 small molecule completed

    1 trial

  21. SR-T100 ® Gel

    Biotech Pharmaceutical Co.,

    Actinic Keratosis

    phase 2 small molecule completed

    1 trial

  22. TG-873870 (Nemonoxacin)

    Biotech Pharmaceutical Co.,

    Diabetic Foot Infections

    phase 2 small molecule completed

    1 trial

  23. CD19-TriCAR-T/SILK

    Biotech Pharmaceutical Co.,

    Non-Hodgkin Lymphoma

    phase 1 mab active

    1 trial

  24. LBT-3627

    Biotech Pharmaceutical Co.,

    Parkinson Disease

    phase 1 small molecule active

    1 trial

  25. Nimotuzumab

    Biotech Pharmaceutical Co.,

    Solid Tumors

    phase 1 small molecule active

    1 trial

  26. Nimotuzumab and chemotherapy

    Biotech Pharmaceutical Co.,

    Non-small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  27. Pegfilgrastim

    Biotech Pharmaceutical Co.,

    Breast Cancer

    phase 1 small molecule completed

    1 trial

  28. Peginterferon lambda

    Biotech Pharmaceutical Co.,

    Hepatitis C

    phase 1 mab completed

    1 trial

  29. TSB-9-W1

    Biotech Pharmaceutical Co.,

    Metastatic Colorectal Cancer

    phase 1 small molecule completed

    1 trial

  30. Tuberculosis Vaccine

    Biotech Pharmaceutical Co.,

    Tuberculosis

    phase 1 mab completed

    1 trial

  31. 2wIPV+1sIPV

    Biotech Pharmaceutical Co.,

    Poliomyelitis

    approved mab active

    1 trial

  32. Taneasy 600mg granules

    Biotech Pharmaceutical Co.,

    COPD (Chronic Obstructive Pulmonary Disease)

    approved small molecule completed

    1 trial

  33. rhGM-CSF group

    Biotech Pharmaceutical Co.,

    Mycoses

    approved small molecule completed

    1 trial

  34. ANKASCIN 568-P Red yeast rice capsules

    Biotech Pharmaceutical Co.,

    Hyperlipidemias

    other active

    1 trial

  35. ExoBDNF SWP-CGPA01 (Pediococcus acidilactici)Capsules

    Biotech Pharmaceutical Co.,

    Cognitive Functions Perceptual Disturbances

    other active

    1 trial

  36. Lactobacillus rhamnosus F-1

    Biotech Pharmaceutical Co.,

    Allergic Rhinitis

    other active

    1 trial

  37. Neomycin/ Dexameythasone/Xylometazoline

    Biotech Pharmaceutical Co.,

    Rhinosinusitis

    small molecule completed

    1 trial

  38. Oligo Fucoidan

    Biotech Pharmaceutical Co.,

    NSCLC Stage IV

    other terminated

    1 trial

  39. Umooze

    Biotech Pharmaceutical Co.,

    Benign Prostatic Hyperplasia

    other completed

    1 trial

  40. VABIOTECH-01

    Biotech Pharmaceutical Co.,

    Diphtheria

    mab completed

    1 trial

Frequently asked questions

How many clinical projects does BioMarin Pharmaceutical have?

40 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.